Brand Name: ANKTIVA Generic Name: (nogapendekin alfa inbakicept-pmln). ANKTIVA (nogapendekin alfa inbakicept-pmln) is used to treat BCG unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS).
ANKTIVA is a drug to activate the immune system (the body system that helps fight disease) used together with another drug called Bacillus Calmette-Guerin (BCG) to treat a subtype of non-muscle invasive bladder cancer (NMIBC), called carcinoma in situ (CIS).
Brand Name: | ANKTIVA |
Generic Name: | nogapendekin alfa inbakicept-pmln |
Strength: | 400 mcg/0.4 mL, clear to slightly opalescent and colorless to slightly yellow solution in single-dose vials for intravesical instillation after dilution. |
Manufacturer: | Altor BioScience, LLC, |
Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “ANKTIVA (nogapendekin alfa inbakicept-pmln) solution” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for ANKTIVA (nogapendekin alfa inbakicept-pmln) solution price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.